61 - Keynote Session - Expansion of Eyecare: What's New and What's Next?

Thursday, February 27, 2025

1:45 PM – 3:45 PM EST

Location: Georgia World Congress Center, Sidney Marcus Auditorium

CE Hours: 2

Moderator(s)

Chris Wroten, OD

Denham Springs, LA, United States

Panelist(s)

Julie Rodman, OD, MSc, FAAO

Miami, FL, United States
Lawrence Woodard, MD

Alpharetta, GA, United States
Walter Mayo, OD

Myrtle Beach, SC, United States

Join us to explore the future of eyecare innovation as we dive into the latest in emerging AI, diagnostics, wearable tech, pharma, and surgical advancements. We’ll discover exciting new pharmaceuticals, equipment, and technologies poised to shape the eyecare of tomorrow . Don’t miss this look at what’s new and what’s next!

Learning Objectives:

Upon conclusion of this activity, attendees will be able to:

Understand the Evolution of Wearable Technology in Eyecare
Explore the use of Artificial Intelligence (AI) in Optometric Practice Management
Examine Cutting-Edge Innovations in Cataract Surgery
Analyze Emerging Technologies for Age-Related Macular Degeneration (AMD)
Investigate the Role of Gene Therapy and Cell Therapy in Ophthalmology
Evaluate Advances in the Ophthalmic Pharmaceutical Pipeline

Disclosure(s):

Chris Wroten, OD: Alcon: Consulting Fees ()

Julie Rodman, OD, MSc, FAAO: Apellis: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Astellas: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); iCare: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); LKC: Advisory Committee/Board Member (); Regeneron: Advisory Committee/Board Member (); Visionix: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) ()

Lawrence Woodard, MD: Alcon: Advisory Committee/Board Member (); Glaukos: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Sight Sciences: Advisory Committee/Board Member (); Tarsus: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) ()

Scott Seaburg, OD: EssilorLuxottica: Employee (paid via salary or other compensation such as stock options) ()

Walter Mayo, OD: No financial relationships to disclose